Brainomix
AI software designed to optimize treatment decision-making for stroke patients.
What they do
The company creates automated imaging software that analyzes CT and MRI brain scans to help doctors diagnose and make treatment decisions for stroke and lung diseases. Stroke networks and healthcare systems buy their platform to coordinate urgent care.
The record
- Vertical
- Imaging & Diagnostics
- Sub-segment
- Clinical AI triage
- Product type
- Software as a medical device
- Stage
- Series B
- Headquarters
- Oxford, United Kingdom
- Region
- Europe
- Founded
- 2010
- Total funding
- $21M raised
Notable investors: Boehringer Ingelheim Venture Fund, Parkwalk Advisors, Tencent Holdings, Oxford University Innovation.